Suppr超能文献

从市售结晶胃蛋白酶制剂中分离出的激肽释放酶。

Kallikrein isolated from commercial crystalline pepsin preparations.

作者信息

Ferreira L A, Henriques O B

机构信息

Departamento de Bioquímica e Immunologia, Universidade Federal de Minas Gerais, Belo Horizonte, Brasil.

出版信息

Braz J Med Biol Res. 1987;20(5):511-20.

PMID:3133004
Abstract
  1. An experiment designed to study the relationship between pH and kininogenase activity of three commercial preparations of porcine crystallized pepsin showed that each preparation had two well separated pH optima, pH 4 and 8. 2. From the inhibition spectrum of the pH 8 kininogenase it was concluded that it is a kallikrein of the glandular type, since it proved to be a serine protease and was insensitive to protein trypsin inhibitors. 3. Kallikrein activity can be separated from pepsin by affinity chromatography on Sepharose-4B-Pro-Phe-agmatine. This separation permitted us to obtain purified material with kallikrein specific activity 43 times higher than that of crude pepsin and which showed a single band on polyacrylamide gel electrophoresis. 4. The kallikrein activity was found to have a molecular weight of 36 kDal and a Michaelis constant of 25 microM when acting on Bz-Pro-Phe-Arg-p-nitroanilide at pH 8.6. 5. On the basis of these properties, kallikrein from commercial pepsin resembles the kallikreins previously described from rat or human stomach.
摘要
  1. 一项旨在研究三种市售猪结晶胃蛋白酶制剂的pH值与激肽原酶活性之间关系的实验表明,每种制剂都有两个分离良好的最适pH值,即pH 4和pH 8。2. 从pH 8激肽原酶的抑制谱可以得出结论,它是腺型激肽释放酶,因为它被证明是一种丝氨酸蛋白酶,并且对蛋白质类胰蛋白酶抑制剂不敏感。3. 可以通过在琼脂糖-4B-脯氨酰-苯丙氨酸-胍丁胺上进行亲和层析将激肽释放酶活性与胃蛋白酶分离。这种分离使我们能够获得比粗制胃蛋白酶的激肽释放酶比活性高43倍的纯化物质,并且该物质在聚丙烯酰胺凝胶电泳上显示出单一条带。4. 当在pH 8.6作用于Bz-脯氨酰-苯丙氨酸-精氨酸-对硝基苯胺时,发现激肽释放酶活性的分子量为36 kDa,米氏常数为25 μM。5. 根据这些特性,市售胃蛋白酶中的激肽释放酶类似于先前从大鼠或人胃中描述的激肽释放酶。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验